Pharmacokinetics of Clindamycin in Obese and Nonobese Children
Michael J. Smith(Duke University), Kevin Watt(University of Utah), Michael D. Reed(Akron Children's Hospital), Jennifer L. Goldman(Children's Mercy Hospital), Michael Cohen‐Wolkowiez(Duke University), Karen Martz(Emmes (United States)), Ravinder Anand(Population Health Research Institute), Katherine Berezny(Duke University), Daniel González(University of North Carolina at Chapel Hill), Daniel K. Benjamin(Duke University), Janice E. Sullivan(University of Louisville), P. Brian Smith(Duke University), Ram Yogev(Northwestern University)
Cited by 41
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study
|The Lancet|2016|485
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337